These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15699477)

  • 41. Smoking history and prior surgical resection predict sensitivity to gefitinib in advanced non-small-cell lung cancer.
    Matsuura K; Kudoh S; Yoshimura N; Kimura T; Mitsuoka S; Hirata K; Yoshikawa J; Iwao H
    Osaka City Med J; 2006 Jun; 52(1):1-8. PubMed ID: 16986358
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations.
    Morita S; Okamoto I; Kobayashi K; Yamazaki K; Asahina H; Inoue A; Hagiwara K; Sunaga N; Yanagitani N; Hida T; Yoshida K; Hirashima T; Yasumoto K; Sugio K; Mitsudomi T; Fukuoka M; Nukiwa T
    Clin Cancer Res; 2009 Jul; 15(13):4493-8. PubMed ID: 19531624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Skin rash as a surrogate marker of clinical response of targeted therapy using gefitinib in advanced or metastatic non-small-cell lung cancer--a retrospective study.
    Acharyya S; Sau S; Dasgupta P; Chakraborty A; Gangopadhyay S
    J Indian Med Assoc; 2012 Jul; 110(7):474-6, 493. PubMed ID: 23520673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gefitinib ("Iressa"): a new therapy for advanced non-small-cell lung cancer.
    Reck M; Gatzemeier U
    Respir Med; 2005 Mar; 99(3):298-307. PubMed ID: 15733505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-comparative monotherapy trials of ZD1839 in previously treated non-small cell lung cancer patients.
    Herbst RS
    Semin Oncol; 2003 Feb; 30(1 Suppl 1):30-8. PubMed ID: 12644982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New directions in oncology nursing care: focus on gefitinib in patients with lung cancer.
    Pizzo B
    Clin J Oncol Nurs; 2004 Aug; 8(4):385-92. PubMed ID: 15354925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of ZD1839 on non-small cell lung cancer-related symptoms as measured by the functional assessment of cancer therapy-lung scale.
    Cella D
    Semin Oncol; 2003 Feb; 30(1 Suppl 1):39-48. PubMed ID: 12644983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lessons from the ("Iressa" Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations.
    Stahel R; Rossi A; Petruzelka L; Kosimidis P; de Braud F; Bernardo MM; Souquet PJ; Parra HS; Gridelli C
    Br J Cancer; 2003 Dec; 89 Suppl 2(Suppl 2):S19-23. PubMed ID: 14661049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib.
    Chiu CH; Shih YN; Tsai CM; Liou JL; Chen YM; Perng RP
    Lung Cancer; 2007 Aug; 57(2):213-21. PubMed ID: 17449138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Gefitinib in the treatment of advanced non-small-cell lung cancer].
    Zhang L; Yu SY
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):539-41. PubMed ID: 17147123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer).
    Thatcher N; Chang A; Parikh P; Rodrigues Pereira J; Ciuleanu T; von Pawel J; Thongprasert S; Tan EH; Pemberton K; Archer V; Carroll K
    Lancet; 2005 Oct 29-Nov 4; 366(9496):1527-37. PubMed ID: 16257339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Gefitinib in the treatment of refractory non-small cell lung cancer].
    Xu JF; Zhou CC; Li AW
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):938-40. PubMed ID: 18478936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of gefitinib in lung cancer treatment.
    Giaccone G
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4233s-4237s. PubMed ID: 15217964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gefitinib in patients with advanced non-small cell lung cancer (NSCLC): the expanded access protocol experience at the University of Pennsylvania.
    Veronese ML; Algazy K; Bearn L; Eaby B; Alavi J; Evans T; Stevenson JP; Shults J
    Cancer Invest; 2005; 23(4):296-302. PubMed ID: 16100941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improvements in quality of life and disease-related symptoms in patients with advanced non-small cell lung cancer treated with gefitinib.
    Zhang XT; Li LY; Wang SL; Mu XL; Wang MZ; Song W
    Chin Med J (Engl); 2005 Oct; 118(19):1661-4. PubMed ID: 16232354
    [No Abstract]   [Full Text] [Related]  

  • 56. FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets.
    Cohen MH; Williams GA; Sridhara R; Chen G; Pazdur R
    Oncologist; 2003; 8(4):303-6. PubMed ID: 12897327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gefitinib treatment for non-small cell lung cancer -- a study including patients with poor performance status.
    Su WP; Yang CH; Yu CJ; Shih JY; Hsu C; Yang PC
    J Formos Med Assoc; 2005 Aug; 104(8):557-62. PubMed ID: 16193176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quality-of-life benefits and evidence of antitumour activity for patients with brain metastases treated with gefitinib.
    Katz A; Zalewski P
    Br J Cancer; 2003 Dec; 89 Suppl 2(Suppl 2):S15-8. PubMed ID: 14661048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1).
    Hirsh V; Cadranel J; Cong XJ; Fairclough D; Finnern HW; Lorence RM; Miller VA; Palmer M; Yang JC
    J Thorac Oncol; 2013 Feb; 8(2):229-37. PubMed ID: 23328549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of ZD1839 (Iressa, gefitinib) treatment on symptoms and quality of life in patients with advanced non-small cell lung cancer.
    Natale RB
    Semin Oncol; 2004 Jun; 31(3 Suppl 9):23-30. PubMed ID: 15206079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.